NASDAQ$OMDA
Omada Health Inc · Q1 2026 earnings
Q1 2026 earnings ·
Briefing
Omada Health reported Q1 2026 revenue of $78.0M with a net loss of $3.0M and diluted loss per share of $0.05.
For the quarter ended March 31, 2026, Omada Health total revenue grew 42% to $78.0 million. Net loss was $3.0 million versus $9.4 million a year ago. Diluted loss per share was $0.05 versus $1.15 on a much smaller pre-IPO share count. The digital chronic-care platform continues scaling employer and health-plan contracts.
- Revenue of $78.0M (+42% YoY).
- Net loss narrowed to $3.0M.
- Diluted loss per share of $0.05.
- Post-IPO share count ~59M weighted average.
- Gross margin improvement on scale.
Headline financials
Revenue & EPS history
Omada Health Inc · Revenue · Quarterly
$78M
Forward guidance
Recent IPO company; full-year guidance provided in earnings releases rather than this 10-Q.
Tailwinds
- Strong revenue growth with improving losses.
- Large addressable market in cardiometabolic care.
Headwinds
- Still GAAP unprofitable.
- Customer concentration in health plans.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 4 quarterly earnings reports · overlaid with Q1 2026
-3.9%
Avg return
Earnings day
+0.1%
Avg return
5 days after
+1.7%
Avg return
30 days after
25%
1 / 4 earnings
Positive
+3.3%
Q4 2025
Best reaction
-9.5%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.5% | -2.1% | +9.4% | |
| Q4 2025 | +3.3% | +1.0% | -7.5% | |
| Q3 2025 | -7.1% | -1.9% | -20.0% | |
| Q2 2025 | -2.3% | +3.2% | +24.8% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro